Peripheral Neuropathy Trial, Recruiting NCT06956664 Sponsor: Çankırı Karatekin University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06956664
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years
  • People whose lumbar (lower back) disc herniation has been confirmed by an MRI scan
  • People who received a specific type of lower back steroid injection (called a caudal epidural steroid injection) at Çankırı State Hospital within the past 2 weeks
  • People who still have lower back or leg pain of at least 3 out of 10 on a pain scale after that injection
  • People who have been cleared by a doctor to safely do moderate aerobic exercise and core-strengthening exercise, with no heart or joint/bone conditions preventing this
  • People who are able to attend supervised physiotherapy sessions three times per week for six weeks
  • People who are willing and able to sign a consent form and follow the study procedures
  • People who can read and write Turkish to at least a primary school level, in order to complete the study questionnaires

Who may not be able to join:

  • People with a serious ongoing health condition that is not well managed, such as poorly controlled diabetes, heart failure, or active liver disease
  • People showing serious neurological warning signs, such as spinal cord pressure problems or a condition called cauda equina syndrome (confirm with trial site)
  • People who have previously had surgery on the affected disc in their lower back
  • People who are currently pregnant or planning to become pregnant during the study period
  • People with a severe muscle, bone, heart, or breathing condition that would make exercise unsafe
  • People who are currently taking steroid tablets or strong opioid pain medicines that cannot be kept at a stable dose for the whole duration of the trial
  • People who have an active legal claim or workers' compensation case related to their lower back pain
  • People who are not able to communicate effectively with the study team or follow instructions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 376 218 95 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Çankırı Karatekin University
Registry
ClinicalTrials.gov
Start date
28 April 2025
Est. completion
15 January 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in Pain Intensity (Numeric Rating Scale, 0-10)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov